Name: AZ6102
Price: 273.00 USD

- Overview
  - Please contact us at for specific academic pricing.
    
    Background
    
    IC50: 1 and 3 nM for TNKS2 and TNKS1, respectivelyAZ6102 is a TNKS1/2 inhibitor.Inhibition of the poly(ADP-ribose) polymerase (PARP) catalytic domain of the tankyrases (TNKS1 and TNKS2) is reported to inhibit the Wnt pathway by increasing stabilization of Axin. The canonical Wnt pathway plays a critical role in adult tissue homeostasis, embryonic development, as well as cancer. In vitro: AZ6102 was identified as a potent TNKS1/2 inhibitor with 100-fold selectivity against other PARP family enzymes including PARPs 1, 2, and 6. In addition, AZ6102 showed a 5 nM IC50 against Wnt pathway in DLD-1 cells [1]. In vivo: In animal study, AZ6102 was intravenously dosed to nude mice at 25 mg/kg, and the results showed that AZ6102 had a clearance of 24 mL/min·kg and a half-life of 4 h. The bioavailability of AZ6102 in mouse and rat was only moderate at 12% and 18%, respectively. In addition, AZ6102 was used as an intravenous probe compound to evaluate the in vivo effects of TNKS1/2 inhibition on normal tissue and tumor xenografts, however, the results of such experiments have not be released so far [1]. Clinical trial: Up to now, AZ6102 is still in the preclinical development stage.
- Properties
  - Alternative Name
    
    2-(4-(6-((3S,5R)-3,5-dimethylpiperazin-1-yl)-4-methylpyridin-3-yl)phenyl)-7-methyl-3H-pyrrolo[2,3-d]pyrimidin-4(7H)-one
    
    CAS Number
    
    1645286-75-4
    
    Molecular Formula
    
    C25H28N6O
    
    Molecular Weight
    
    428.53
    
    Appearance
    
    A crystalline solid
    
    Purity
    
    98.00%
    
    Solubility
    
    Soluble in DMSO
    
    Storage
    
    Store at -20°C
    
    * For Research Use Only

AZ6102

AZ6102

Background

We Also Recommend

A-1155463

A-1331852

FRAX486